药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Rescinnamine
Nemonoxacin
The risk or severity of QTc prolongation can be increased when Nemonoxacin is combined with Panobinostat.
Rescinnamine
Telavancin
The risk or severity of QTc prolongation can be increased when Telavancin is combined with Panobinostat.
Rescinnamine
Tucidinostat
The risk or severity of QTc prolongation can be increased when Tucidinostat is combined with Panobinostat.
Rescinnamine
Tedisamil
The risk or severity of QTc prolongation can be increased when Tedisamil is combined with Panobinostat.
Rescinnamine
Garenoxacin
The risk or severity of QTc prolongation can be increased when Garenoxacin is combined with Panobinostat.
Rescinnamine
Technetium Tc-99m ciprofloxacin
The risk or severity of QTc prolongation can be increased when Technetium Tc-99m ciprofloxacin is combined with Panobinostat.
Rescinnamine
Pracinostat
The risk or severity of QTc prolongation can be increased when Pracinostat is combined with Panobinostat.
Rescinnamine
Azimilide
The risk or severity of QTc prolongation can be increased when Azimilide is combined with Panobinostat.
Rescinnamine
Fluspirilene
The risk or severity of QTc prolongation can be increased when Fluspirilene is combined with Panobinostat.
Rescinnamine
Prenylamine
The risk or severity of QTc prolongation can be increased when Prenylamine is combined with Panobinostat.
Rescinnamine
Terlipressin
The risk or severity of QTc prolongation can be increased when Terlipressin is combined with Panobinostat.
Rescinnamine
Aceprometazine
The risk or severity of QTc prolongation can be increased when Aceprometazine is combined with Panobinostat.
Rescinnamine
Probucol
The risk or severity of QTc prolongation can be increased when Probucol is combined with Panobinostat.
Rescinnamine
Artemether
The risk or severity of QTc prolongation can be increased when Artemether is combined with Panobinostat.
Rescinnamine
Terodiline
The risk or severity of QTc prolongation can be increased when Panobinostat is combined with Terodiline.
Rescinnamine
Macimorelin
The risk or severity of QTc prolongation can be increased when Panobinostat is combined with Macimorelin.
Rescinnamine
Asenapine
The risk or severity of QTc prolongation can be increased when Panobinostat is combined with Asenapine.
Rescinnamine
Temafloxacin
The risk or severity of QTc prolongation can be increased when Panobinostat is combined with Temafloxacin.
Rescinnamine
Lithium cation
The risk or severity of QTc prolongation can be increased when Panobinostat is combined with Lithium cation.
Rescinnamine
Halofantrine
The risk or severity of QTc prolongation can be increased when Panobinostat is combined with Halofantrine.